These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27822925)

  • 1. National Rules for Drug-Drug Interactions: Are They Appropriate for Tertiary Hospitals?
    Cho I; Lee JH; Choi J; Hwang H; Bates DW
    J Korean Med Sci; 2016 Dec; 31(12):1887-1896. PubMed ID: 27822925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wide variation and patterns of physicians' responses to drug-drug interaction alerts.
    Cho I; Lee Y; Lee JH; Bates DW
    Int J Qual Health Care; 2019 Mar; 31(2):89-95. PubMed ID: 29741633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences among admitting departments in alerts and alert overrides for drug-drug interaction.
    Ahn EK; Kam HJ; Park DK; Jung EY; Lee Y; Park RW
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):390-7. PubMed ID: 24677664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
    Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
    J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Investigation of Drug-Drug Interaction Alert Overrides at a Pediatric Hospital.
    Humphrey K; Jorina M; Harper M; Dodson B; Kim SY; Ozonoff A
    Hosp Pediatr; 2018 May; 8(5):293-299. PubMed ID: 29700011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-priority and low-priority drug-drug interactions in different international electronic health record systems: A comparative study.
    Cornu P; Phansalkar S; Seger DL; Cho I; Pontefract S; Robertson A; Bates DW; Slight SP
    Int J Med Inform; 2018 Mar; 111():165-171. PubMed ID: 29425628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and implementation of medication-related clinical rules for obstetrics, gynaecology, and paediatric outpatients.
    Chen Q; Wang L; Lin M; Chen W; Wu W; Chen Y
    Eur J Hosp Pharm; 2024 Feb; 31(2):101-106. PubMed ID: 35523537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
    Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
    Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Evaluation of Drug-Drug Interaction Alerts Produced by Clinical Decision Support Systems in a Tertiary Hospital.
    Alanazi A; Alalawi W; Aldosari B
    Cureus; 2023 Aug; 15(8):e43141. PubMed ID: 37692642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we heeding the warning signs? Examining providers' overrides of computerized drug-drug interaction alerts in primary care.
    Slight SP; Seger DL; Nanji KC; Cho I; Maniam N; Dykes PC; Bates DW
    PLoS One; 2013; 8(12):e85071. PubMed ID: 24386447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Design for Drug-Drug Interaction Alerts Improves Prescribing Efficiency.
    Russ AL; Chen S; Melton BL; Johnson EG; Spina JR; Weiner M; Zillich AJ
    Jt Comm J Qual Patient Saf; 2015 Sep; 41(9):396-405. PubMed ID: 26289234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and nature of drug-drug interactions in a Dutch university hospital.
    Zwart-van Rijkom JE; Uijtendaal EV; ten Berg MJ; van Solinge WW; Egberts AC
    Br J Clin Pharmacol; 2009 Aug; 68(2):187-93. PubMed ID: 19694737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Think time: A novel approach to analysis of clinicians' behavior after reduction of drug-drug interaction alerts.
    Schreiber R; Gregoire JA; Shaha JE; Shaha SH
    Int J Med Inform; 2017 Jan; 97():59-67. PubMed ID: 27919396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
    Ko Y; Malone DC; Skrepnek GH; Armstrong EP; Murphy JE; Abarca J; Rehfeld RA; Reel SJ; Woosley RL
    Drug Saf; 2008; 31(6):525-36. PubMed ID: 18484786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.